Intention-to-treat and per-protocol analyses of eradication rates were 84.1 % ( 37/44 ) and 86.4 % ( 37/43 ) with RAS for 1 week , 88.9 % ( 40/45 ) and 90.9 % ( 40/44 ) for RAS for 2 weeks , 90.9 % ( 40/44 ) and 90.9 % ( 40/44 ) for 1 week-RMS and 87.2 % ( 41/47 ) and 91.1 % ( 41/45 ) with RMS for 2 weeks .